{"entity":{"id":"nct05875168","kind":"trial","name":"First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of DS-3939a in advanced solid tumours, run by Daiichi Sankyo, now recruiting.","summary":"First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT05875168 by Daiichi Sankyo, with 590 participants planned, started 2023-08-18 and due to reach its primary completion in 2026-10-20. Interventions recorded: DS-3939a.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05875168","url":"https://clinicaltrials.gov/study/NCT05875168"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["daiichi-sankyo"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT05875168","phase":"1/2","setting":"Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors","sponsor":"Daiichi Sankyo","enrolled":590,"outcomes":[]},"route":"/trials/nct05875168/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"daiichi-sankyo","kind":"company","name":"Daiichi Sankyo","route":"/companies/daiichi-sankyo/"}]}}